StonvexLoading…
StonvexStonvexStonvexCore line items from NWBI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $160.12M | $201.55M | $749.67M | $546.84M | $352.17M |
Operating Income | Not available | $66.66M | $162.79M | $104.09M | $100.62M |
Net Income | Not available | $50.54M | $126.01M | $80.30M | $77.13M |
EPS (Diluted) | $0.34 | $0.34 | $0.92 | $0.61 | $0.60 |
Total Assets | Not available | $16.91B | $16.77B | $16.38B | $14.49B |
Total Liabilities | Not available | $15.00B | $14.88B | $14.53B | $12.84B |
Cash & Equivalents | Not available | $286.71M | $233.65M | $278.82M | $267.07M |
Free Cash Flow OCF − CapEx | Not available | $69.56M | $141.78M | $138.13M | $99.83M |
Shares Outstanding | Not available | 146.30M | 146.11M | 146.10M | 127.84M |